Fresenius Medical Care-NxStage deal gets second request from FTC
MLex Summary: Fresenius Medical Care received a second request Oct. 18 for additional information from the US Federal Trade Commission on its proposed deal with NxStage Medical, the company said in...To view the full article, register now.
Already a subscriber? Click here to view full article